Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aaron T Ludwig

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 18, 2005
Depsipeptide (FR901228) enhances the cytotoxic activity of TRAIL by redistributing TRAIL receptor to membrane lipid raftsRebecca L Vanoosten, Jill M Moore, Aaron T Ludwig, et al.
Journal of Endourology|May 21, 2010
Robot-assisted posterior retroperitoneoscopic adrenalectomyAaron T Ludwig, Kristofer R Wagner, Patrick S Lowry, et al.
Urology|March 23, 2005
Two-surgeon versus single-surgeon radical cystectomy and urinary diversion: impact on patient outcomes and costsAaron T Ludwig, Lavanya Inampudi, Michael A O'Donnell, et al.
Journal of Pediatric Surgery|February 24, 2009
A novel SOX9 mutation, 972delC, causes 46,XY sex-reversed campomelic dysplasia with nephrocalcinosis, urolithiasis, and dysgerminomaNicholas G Cost, Aaron T Ludwig, Duncan T Wilcox, et al.
Cancer Research|May 20, 2004
Tumor necrosis factor-related apoptosis-inducing ligand: a novel mechanism for Bacillus Calmette-Guérin-induced antitumor activityAaron T Ludwig, Jill M Moore, Yi Luo, et al.
Experimental Hematology|November 13, 2004
Expression of TNF-related apoptosis-inducing ligand (TRAIL) in megakaryocytes and plateletsScott A Crist, Bennett D Elzey, Aaron T Ludwig, et al.
Blood|July 23, 2005
Neutrophil stimulation with Mycobacterium bovis bacillus Calmette-Guerin (BCG) results in the release of functional soluble TRAIL/Apo-2LTroy J Kemp, Aaron T Ludwig, James K Earel, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 18, 2005
Depsipeptide (FR901228) enhances the cytotoxic activity of TRAIL by redistributing TRAIL receptor to membrane lipid raftsRebecca L Vanoosten, Jill M Moore, Aaron T Ludwig, et al.
Journal of Endourology|May 21, 2010
Robot-assisted posterior retroperitoneoscopic adrenalectomyAaron T Ludwig, Kristofer R Wagner, Patrick S Lowry, et al.
Urology|March 23, 2005
Two-surgeon versus single-surgeon radical cystectomy and urinary diversion: impact on patient outcomes and costsAaron T Ludwig, Lavanya Inampudi, Michael A O'Donnell, et al.
Journal of Pediatric Surgery|February 24, 2009
A novel SOX9 mutation, 972delC, causes 46,XY sex-reversed campomelic dysplasia with nephrocalcinosis, urolithiasis, and dysgerminomaNicholas G Cost, Aaron T Ludwig, Duncan T Wilcox, et al.
Cancer Research|May 20, 2004
Tumor necrosis factor-related apoptosis-inducing ligand: a novel mechanism for Bacillus Calmette-Guérin-induced antitumor activityAaron T Ludwig, Jill M Moore, Yi Luo, et al.
Experimental Hematology|November 13, 2004
Expression of TNF-related apoptosis-inducing ligand (TRAIL) in megakaryocytes and plateletsScott A Crist, Bennett D Elzey, Aaron T Ludwig, et al.
Blood|July 23, 2005
Neutrophil stimulation with Mycobacterium bovis bacillus Calmette-Guerin (BCG) results in the release of functional soluble TRAIL/Apo-2LTroy J Kemp, Aaron T Ludwig, James K Earel, et al.
Pageof 1